NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 126 filers reported holding NURIX THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $372,596 | -21.9% | 47,404 | -0.7% | 0.00% | – |
| Q2 2023 | $476,842 | +10.9% | 47,732 | -1.4% | 0.00% | – |
| Q1 2023 | $430,094 | +156.9% | 48,434 | +217.6% | 0.00% | – |
| Q4 2022 | $167,423 | -15.9% | 15,248 | -0.2% | 0.00% | – |
| Q3 2022 | $199,000 | +18.5% | 15,278 | +14.9% | 0.00% | – |
| Q2 2022 | $168,000 | -10.2% | 13,297 | -0.4% | 0.00% | – |
| Q1 2022 | $187,000 | -51.0% | 13,349 | +1.4% | 0.00% | – |
| Q4 2021 | $382,000 | -20.4% | 13,171 | -17.8% | 0.00% | – |
| Q3 2021 | $480,000 | +34.1% | 16,024 | +18.8% | 0.00% | – |
| Q2 2021 | $358,000 | – | 13,484 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $18,210,601 | 1.88% |
| DAFNA Capital Management LLC | 556,695 | $5,561,383 | 1.52% |
| Deep Track Capital, LP | 2,997,830 | $29,948,322 | 1.39% |
| Redmile Group, LLC | 2,857,309 | $28,544,517 | 1.10% |
| WestHill Financial Advisors, Inc. | 283,333 | $2,830,497 | 0.80% |
| Boxer Capital, LLC | 1,224,892 | $12,237 | 0.57% |
| AtonRa Partners | 30,142 | $301,119 | 0.47% |
| Affinity Asset Advisors, LLC | 100,000 | $999,000 | 0.35% |
| HARVARD MANAGEMENT CO INC | 314,762 | $3,144 | 0.31% |
| WASATCH ADVISORS LP | 3,869,775 | $38,659,052 | 0.23% |